(Q40579509)

21 September 2017

title

Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy (English)

1 reference

21 September 2017

1 reference

1 reference

1 reference

James Lewis Abbruzzese

series ordinal

4

object named as

James L Abbruzzese

1 reference

21 September 2017

Renato Lenzi

1

1 reference

21 September 2017

Suayib Yalcin

series ordinal

2

1 reference

21 September 2017

Douglas B Evans

series ordinal

3

1 reference

21 September 2017

language of work or name

1 reference

1 January 2002

1 reference

21 September 2017

1 reference

21 September 2017

volume

20

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

464-472

1 reference

21 September 2017

cites work

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

CPT-11 in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

Tau expression in model adenocarcinomas correlates with docetaxel sensitivity in tumour-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002146

21 January 2018

Identifiers

DOI

10.1081/CNV-120002146

1 reference

21 September 2017

1 reference